US 11673954
Single-domain antibodies and variants thereof against PD-L1
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 11673954 (Single-domain antibodies and variants thereof against PD-L1) held by Nanjing Legend Biotech Co., Ltd expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nanjing Legend Biotech Co., Ltd
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P